ASFX logo

American Scientific Resources, Incorporated (ASFX)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

American Scientific Resources, Incorporated (ASFX) with AI Score 50/100 (Hold). American Scientific Resources, Incorporated is in liquidation. Market cap: 0, Sector: Healthcare.

Last analyzed: Mar 16, 2026
American Scientific Resources, Incorporated is in liquidation. The company formerly developed, manufactured, and distributed medical products and devices for children and adults, including thermometers, nebulizers, and other healthcare-related items.
50/100 AI Score

American Scientific Resources, Incorporated (ASFX) Healthcare & Pipeline Overview

Employees5
HeadquartersWeston, US
IPO Year1997

American Scientific Resources, Incorporated, currently in liquidation, formerly operated in the medical instruments and supplies sector, focusing on developing and distributing products for both children and adults. Its product line included thermometers, respiratory devices, and other healthcare aids, primarily distributed through retail channels and online platforms. The company was based in Weston, Florida.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

Investment Thesis

American Scientific Resources, Incorporated presents a complex investment case due to its current liquidation status. The company's past focus on developing and distributing medical devices for children and adults suggests a potential market opportunity, but its financial instability and subsequent liquidation significantly undermine any investment appeal. The company's negative free cash flow of $-0.00B and a market capitalization of $0.00B further highlight its distressed state. While its products once addressed specific needs in the healthcare market, the liquidation process raises substantial concerns about asset recovery and potential returns for investors. The company's beta of -3.31 may indicate low volatility, but this is largely irrelevant given its liquidation status.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $0.00B reflects the company's liquidation status and lack of active trading.
  • Gross Margin of 21.5% indicates the profitability of products before liquidation, but is not indicative of current financial health.
  • Free Cash Flow of $-0.00B highlights the company's financial struggles leading to liquidation.
  • Beta of -3.31 suggests a low correlation with the market, but is not a relevant metric given the company's current state.
  • Liquidation status indicates significant financial distress and potential loss of investment.

Competitors & Peers

Strengths

  • N/A: Given the company's liquidation status, it no longer possesses any strengths.

Weaknesses

  • Liquidation status
  • Financial instability
  • Lack of ongoing operations

Catalysts

  • N/A: The company is in liquidation.

Risks

  • Ongoing: Liquidation process may result in complete loss of investment.
  • Ongoing: Lack of financial transparency due to OTC Other status.
  • Ongoing: Minimal trading volume and liquidity.

Growth Opportunities

  • N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
  • N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
  • N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
  • N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
  • N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.

Opportunities

  • N/A: Given the company's liquidation status, it has no opportunities.

Threats

  • N/A: Given the company's liquidation status, it faces no threats.

Competitive Advantages

  • N/A: Given the company's liquidation status, it no longer possesses a sustainable competitive advantage or 'moat'.

About ASFX

American Scientific Resources, Incorporated was a developer, manufacturer, and distributor of medical products and devices aimed at both children and adults. Founded with the mission of providing innovative healthcare solutions, the company offered a diverse portfolio of products designed to address various needs within the healthcare market. Its product lineup included the Thermofocus 5-in-1 non-contact clinical thermometer, VeraTemp and VeraTemp+ non-contact thermometers, and the Scald Safe Water temperature disc, designed to prevent scalding in baby baths. Additionally, the company offered WhistleWatch, a flow monitoring device for children with respiratory issues, and the Kidz-Med portable ultrasonic nebulizer for treating conditions like asthma and bronchitis. Further expanding its product range, American Scientific Resources provided the Kidz-Med Medicine Dispenser, the Kidz-Med Mommy Recorder, Bip DVDs, the Mebby product line (including breast pumps and baby bottles), and Wee Target. The company also offered the Disintegrator, a home needle and lancet destruction device. Distribution was primarily achieved through retail drug and grocery chains, medical suppliers, its own website, and other online platforms. However, on February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against the company, and the petition was approved on March 28, 2012. As of 2026, American Scientific Resources, Inc. is in liquidation.

What They Do

  • Developed and manufactured medical products for children and adults.
  • Offered non-contact clinical thermometers.
  • Provided respiratory monitoring devices.
  • Developed devices for safe baby care, such as bath water temperature discs.
  • Distributed products through retail drug and grocery chains.
  • Sold products through its website and online platforms.

Business Model

  • Developed and manufactured medical devices.
  • Distributed products through retail and online channels.
  • Generated revenue through product sales.

Industry Context

American Scientific Resources, Incorporated operated within the medical instruments and supplies industry, a sector characterized by continuous innovation and stringent regulatory oversight. The market is driven by factors such as an aging population, increasing prevalence of chronic diseases, and technological advancements in medical devices. Competitors in this space, such as CEVE, HCANF, HSMD, LOWLF, and MDIT, operate in a dynamic environment where product differentiation and regulatory compliance are critical for success. However, given American Scientific Resources' liquidation status, it no longer actively participates in or influences the competitive landscape.

Key Customers

  • Parents and caregivers of infants and children.
  • Adults requiring medical devices for personal health monitoring.
  • Retail drug and grocery chains.
  • Medical suppliers.
AI Confidence: 75% Updated: Mar 16, 2026

Financials

Chart & Info

American Scientific Resources, Incorporated (ASFX) stock price: Price data unavailable

Latest News

No recent news available for ASFX.

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ASFX.

Price Targets

Wall Street price target analysis for ASFX.

MoonshotScore

50/100

What does this score mean?

The MoonshotScore rates ASFX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

ASFX OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or have chosen not to provide current information to the market. These securities are often speculative and carry a high degree of risk due to the limited information available and the potential for fraud or manipulation. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face minimal listing requirements, resulting in greater uncertainty for investors. This tier includes companies in bankruptcy, liquidation, or those with questionable business operations.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Liquidity for stocks on the OTC Other tier is typically very low, with wide bid-ask spreads and limited trading volume. This can make it difficult for investors to buy or sell shares without significantly impacting the price. The lack of liquidity increases the risk of holding these securities, as it may be challenging to exit a position quickly or at a desired price. Given ASFX's liquidation status, trading activity is likely minimal or non-existent.
OTC Risk Factors:
  • Limited or no financial disclosure
  • High potential for fraud or manipulation
  • Low liquidity and wide bid-ask spreads
  • Bankruptcy or liquidation status
  • Lack of regulatory oversight
Due Diligence Checklist:
  • Verify the company's liquidation status with the US Bankruptcy Court for the Southern District of Florida.
  • Review any available financial reports, if any exist.
  • Assess the potential for asset recovery in liquidation.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with OTC Other securities.
  • Check for any regulatory actions or legal proceedings against the company.
Legitimacy Signals:
  • N/A: Given the company's liquidation status, there are no legitimacy signals.

ASFX Healthcare Stock FAQ

What does American Scientific Resources, Incorporated do?

American Scientific Resources, Incorporated developed, manufactured, and distributed medical products and devices for children and adults. Its product line included non-contact thermometers, respiratory monitoring devices, and other healthcare-related items. The company primarily distributed its products through retail drug and grocery chains, medical suppliers, and online platforms. However, the company is currently in liquidation, and is no longer operating.

What do analysts say about ASFX stock?

Given American Scientific Resources, Incorporated's liquidation status, there is no current analyst coverage or consensus. The company's financial metrics, such as its market capitalization of $0.00B and negative free cash flow, reflect its distressed state. Any historical analyst ratings or price targets are no longer relevant due to the company's liquidation. Investors should focus on the liquidation process and potential asset recovery, if any.

What are the main risks for ASFX?

The primary risk for American Scientific Resources, Incorporated is its liquidation status, which could result in a complete loss of investment. As an OTC Other stock, it faces limited financial disclosure and regulatory oversight, increasing the potential for fraud or manipulation. Low liquidity and wide bid-ask spreads further exacerbate the risks. Investors should exercise extreme caution and conduct thorough due diligence before considering any investment in ASFX.

What are the key factors to evaluate for ASFX?

American Scientific Resources, Incorporated (ASFX) currently holds an AI score of 50/100, indicating moderate score. Key strength: N/A: Given the company's liquidation status, it no longer possesses any strengths.. Primary risk to monitor: Ongoing: Liquidation process may result in complete loss of investment.. This is not financial advice.

How frequently does ASFX data refresh on this page?

ASFX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ASFX's recent stock price performance?

Recent price movement in American Scientific Resources, Incorporated (ASFX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: N/A: Given the company's liquidation status, it no longer possesses any strengths.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ASFX overvalued or undervalued right now?

Determining whether American Scientific Resources, Incorporated (ASFX) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ASFX?

Before investing in American Scientific Resources, Incorporated (ASFX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available historical data and the company's liquidation status.
  • The company is in liquidation, which significantly impacts its financial viability and investment potential.
Data Sources

Popular Stocks